Announcements Trials

Browse Landscape

Phase

Phase 1 7 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 7 Cyclophosphamide 5 Metformin 4 durvalumab 3 Vincristine 3 Radiation 3 Imiquimod 3 Fluorouracil 3 antitumor A 2 Testosterone 2 Surveys and Questionnaires 2 Rituximab 2 Prednisone 2 Positron Emission Tomography Computed Tomography 2 Oxaliplatin 2 Leucovorin 2 Lapatinib 2 Immunoglobulin G 2 HhAntag691 2 Doxorubicin 2 Disulfides 2 Cisplatin 2 Biopsy 2 xentuzumab 1 tremelimumab 1 ribociclib 1 posaconazole 1 pexidartinib 1 perflutren 1 pazopanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Has results × xentuzumab × Clear all

NCT05110495 2025-02-17

WINGMEN

University of Oxford

Phase EARLY_PHASE1 Completed

27 enrolled 9 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡